Laboratory Testing Core
Laboratory Testing Core
批准号:
8247047
负责人:
Daniel A Lawrence
金额:
$22.77万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-04-01 至 2013-03-31
关键词:
AnticoagulantsAntigensAtherosclerosisBiological AssayBleeding time procedureBlood PlateletsChemicalsCoagulation ProcessDevelopmentEnsureFibrin fragment DFibrinolysisGenomicsGoalsImmunoassayIndividualInflammatoryLaboratoriesLibrariesLipidsMeasuresMouse ProteinMouse StrainsMusObesityPlasmaPlasminogen ActivatorPlasminogen Activator Inhibitor 1Platelet aggregationProteinsResearch PersonnelRiskScreening procedureTechnologyTestingThrombosisTimeVenous ThrombosisZebrafishadipokinescytokinehypercholesterolemianovelprogramssmall moleculesuccess
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Core B: Laboratory Testing Core
The Testing Laboratory Core B has the goal to serve every project in the Program. It will provide an array of
assays assessing fibrinolysis, coagulation, anticoagulant activities, and plasma lipid profiles. The Core will
also provide assays of inflammatory cytokines, and adipokines as well as with established kits for mouse
proteins associated with thrombosis, atherosclerosis and obesity. The specific assays that are available for
each of the projects are indicated below. Core B will also coordinate the high through-put screening of small
molecules by the Center for Chemical Genomics.
Project 1: Core B will perform analysis of plasma PAI-1 levels for both active and inactive PAI-1 and of
plasminogen activator antigen and activity levels. In addition, plasma lipid profiles will be routinely
determined and immunoassays of various inflammatory cytokines as well as adipokines will be measured in
a mutiplex format using the Luminex Technology. High through-put screening of small molecule compound
libraries for the development of novel PAI-1 inactivating agents will also be performed through the Center for
Chemical Genomics.
Project 2: Core B will perform analysis of plasma PAI-1 levels for both active and inactive PAI-1 and of
plasminogen activator antigen and activity levels. Murine plasmas will also be analyzed for increased risk for
thrombosis by determining the levels of plasma coagulation, and anticoagulant proteins in various strains of
mice at baseline, and after venous thrombosis with or without hypercholesterolemia. D-dimer levels will also
be measured. Procoagulant microparticles will also be measured as well as immunoassays of various
inflammatory cytokines.
Project 3: Core B will assist the investigators off Project 3 by assessing platelet function including bleeding
times and platelet aggregation in mice. Fibrinolytic parameters will be determined including PAI-1 and
plasminogen activator levels. Immunoassays of various inflammatory cytokines will also be measured in a
mutiplex format using the Luminex Technology.
Project 4: Core B will assist the investigators of Project 4 by developing novel, assays for
coagulation/fibrinolysis and platelet function in Zebrafish. These assays will include immunoassays and
functional assays such as clotting times as well as factor assays.
The overall goals of the Testing Laboratory Core B are to enhance the success of each individual project by
providing rigorous, standardized assays and to ensure that the combined Program is stronger than each of
its individual parts.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Characterization and targeting of a novel pathway promoting Parkinson’s Disease
-
批准号:10855706
-
项目类别:
-
资助金额:$64.71万
-
财政年份:2023
-
负责人:Daniel A Lawrence
-
依托单位:
A Novel PAI-1 Function Drives Lung Fibrosis
-
批准号:10605479
-
项目类别:
-
资助金额:$69.67万
-
财政年份:2022
-
负责人:Daniel A Lawrence
-
依托单位:
The Role of PAI-1 in Cerebral Microvascular Dysfunction and the Development of Alzheimer’s Disease Neuropathology
-
批准号:10314556
-
项目类别:
-
资助金额:$67.02万
-
财政年份:2021
-
负责人:Daniel A Lawrence
-
依托单位:
The Role of PAI-1 in Cerebral Microvascular Dysfunction and the Development of Alzheimer’s Disease Neuropathology
-
批准号:10629303
-
项目类别:
-
资助金额:$69.12万
-
财政年份:2021
-
负责人:Daniel A Lawrence
-
依托单位:
Mechanism of thrombolytic tPA induced intracerebral hemorrhage after stroke
-
批准号:8655918
-
项目类别:
-
资助金额:$33.68万
-
财政年份:2012
-
负责人:Daniel A Lawrence
-
依托单位:
Mechanism of thrombolytic tPA induced intracerebral hemorrhage after stroke
-
批准号:8487469
-
项目类别:
-
资助金额:$32.83万
-
财政年份:2012
-
负责人:Daniel A Lawrence
-
依托单位:
Mechanism of thrombolytic tPA induced intracerebral hemorrhage after stroke
-
批准号:8345099
-
项目类别:
-
资助金额:$34.02万
-
财政年份:2012
-
负责人:Daniel A Lawrence
-
依托单位:
Characterization of the role of PAI-1 in lipid metabolism
-
批准号:8247042
-
项目类别:
-
资助金额:$22.77万
-
财政年份:2011
-
负责人:Daniel A Lawrence
-
依托单位:
Administrative Core
-
批准号:8247048
-
项目类别:
-
资助金额:$22.77万
-
财政年份:2011
-
负责人:Daniel A Lawrence
-
依托单位:
Laboratory Testing Core
-
批准号:8150067
-
项目类别:
-
资助金额:$23.0万
-
财政年份:2010
-
负责人:Daniel A Lawrence
-
依托单位:
Characterization of the role of PAI-1 in lipid metabolism
-
批准号:8150059
-
项目类别:
-
资助金额:$23.0万
-
财政年份:2010
-
负责人:Daniel A Lawrence
-
依托单位:
Administrative Core
-
批准号:8150068
-
项目类别:
-
资助金额:$23.0万
-
财政年份:2010
-
负责人:Daniel A Lawrence
-
依托单位:
Molecular Genetics of Coagulation Disorders
-
批准号:7657103
-
项目类别:
-
资助金额:$20.12万
-
财政年份:2009
-
负责人:Daniel A Lawrence
-
依托单位:
Novel Targets in Thrombosis and Atherosclerosis
-
批准号:7617234
-
项目类别:
-
资助金额:$152.03万
-
财政年份:2008
-
负责人:Daniel A Lawrence
-
依托单位:
Novel Targets in Thrombosis and Atherosclerosis
-
批准号:8247049
-
项目类别:
-
资助金额:$159.1万
-
财政年份:2008
-
负责人:Daniel A Lawrence
-
依托单位:
Novel Targets in Thrombosis and Atherosclerosis
-
批准号:7797615
-
项目类别:
-
资助金额:$160.99万
-
财政年份:2008
-
负责人:Daniel A Lawrence
-
依托单位:
Novel Targets in Thrombosis and Atherosclerosis
-
批准号:8072042
-
项目类别:
-
资助金额:$159.37万
-
财政年份:2008
-
负责人:Daniel A Lawrence
-
依托单位:
Laboratory Testing Core
-
批准号:7485908
-
项目类别:
-
资助金额:$26.84万
-
财政年份:2008
-
负责人:Daniel A Lawrence
-
依托单位:
Characterization of the role of PAI-1 in lipid metabolism
-
批准号:7485899
-
项目类别:
-
资助金额:$37.07万
-
财政年份:2008
-
负责人:Daniel A Lawrence
-
依托单位:
Administrative Core
-
批准号:7485910
-
项目类别:
-
资助金额:$7.8万
-
财政年份:2008
-
负责人:Daniel A Lawrence
-
依托单位:
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
-
批准号:2022J011295
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:王亚伟
-
依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
-
批准号:30801055
-
项目类别:青年科学基金项目
-
资助金额:19.0万元
-
批准年份:2008
-
负责人:王丽梅
-
依托单位: